Cloning, Characterization, and Inhibition Studies of a β-Carbonic Anhydrase from Brucella suis-Reference-Cited by-同舟云学术

Cloning, Characterization, and Inhibition Studies of a β-Carbonic Anhydrase from Brucella suis

Published:2010-02-16 Issue:5 Volume:53 Page:2277-2285
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Joseph Pascale¹,Turtaut François¹²,Ouahrani-Bettache Safia¹,Montero Jean-Louis²,Nishimori Isao³,Minakuchi Tomoko³,Vullo Daniela⁴,Scozzafava Andrea⁴,Köhler Stephan¹,Winum Jean-Yves²,Supuran Claudiu T.⁴

Affiliation:

1. Centre d’Etudes d’Agents Pathogènes et Biotechnologies pour la Santé (CPBS), UMR 5236 CNRS-UM1-UM2, Université Montpellier II, cc100, Place E. Bataillon, 34095 Montpellier, France

2. Institut des Biomolécules Max Mousseron (IBMM), UMR 5247 CNRS-UM1-UM2, Bâtiment de Recherche Max Mousseron, Ecole Nationale Supérieure de Chimie de Montpellier, 8 rue de l’Ecole Normale, 34296 Montpellier Cedex, France

3. Department of Gastroenterology, Kochi Medical School, Nankoku, Kochi 783-8505, Japan

4. Università degli Studi di Firenze, Polo Scientifico, Laboratorio di Chimica Bioinorganica, Rm. 188, Via della Lastruccia 3, 50019 Sesto Fiorentino (Florence), Italy

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm901855h

Reference58 articles.

1. aNickerson, C. A. and Schurr, M. J.Molecular Paradigms of Infectious Disease: a Bacterial Perspective;Springer Verlag;Munich, 2006; pp1−617;

2. Drugs for bad bugs: confronting the challenges of antibacterial discovery

3. From bench to bedside: stealth of enteroinvasive pathogens

4. Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis

5. Emerging Drugs for Active Tuberculosis

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sulfonamide inhibitors of bacterial carbonic anhydrases;The Enzymes;2024

2. Neisseria gonorrhoeae carbonic anhydrase inhibition;The Enzymes;2024

3. Carbonic anhydrases in bacterial pathogens;The Enzymes;2024

4. Challenges for developing bacterial CA inhibitors as novel antibiotics;The Enzymes;2024

5. An overview of novel antimicrobial carbonic anhydrase inhibitors;Expert Opinion on Therapeutic Targets;2023-09-27